Induction of apoptosis through oxidative stress-related pathways in MCF-7, human breast cancer cells, by ethyl acetate extract of Dillenia suffruticosa

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Tor, Yin S ^a   Yazan, Latifah S ^a   Foo, Jhi B ^a   Armania, Nurdin ^a   Cheah, Yoke K ^a   Abdullah, Rasedee ^a   Imam, Mustapha U ^a   Ismail, Norsharina ^a   Ismail, Maznah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Apoptosis; Breast cancer; Cytotoxic; Dillenia suffruticosa; Oxidative stress pathway

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CATALASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; PROTEIN KINASE B; SUPEROXIDE DISMUTASE;

ADENOCARCINOMA; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE CHECKPOINT; DILLENIACEAE; DRUG EFFECTS; FEMALE; HUMAN; MCF 7 CELL LINE; METABOLISM; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT ROOT; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CATALASE; CELL CYCLE; CELL CYCLE CHECKPOINTS; DILLENIACEAE; FEMALE; HUMANS; MCF-7 CELLS; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 84893743827     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-55     Document Type: Article

References (79)

1. United States Cancer Statistics 1999-2007 Incidence and Mortality Web-based Report http://www.cdc.gov/uscs, United States Cancer Statistics.
2. ACS Cancer Facts and Figures 2012 2012, Cancers with Increasing Incidence Trends, http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf, ACS.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012, 62(1):10--29. http://dx.doi.org/10.3322/caac.20138, 10.3322/caac.20138, 22237781.
4. Forman D, Ward E, Ferlay M, Jemal A, Bray F. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. http://dx.doi.org/10.3322/caac.20107, 10.3322/caac.20107, 21296855.
5. Kaufmann SH, Gores GJ. Apoptosis in cancer: cause and cure. BioEssays 2000, 22(11):1007-1017. http://dx.doi.org/10.1002/1521-1878(200011)22:111007::AID-BIES7>3.0.CO;2-4, 10.1002/1521-1878(200011)22:111007::AID-BIES7>3.0.CO;2-4, 11056477.
6. McGill G, Fisher DE. Apoptosis in tumorigenesis and cancer therapy. Frontiers in Biosci: a J and virtual Lib 1997, 2:d353-d379. http://europepmc.org/abstract/MED/9230063.
7. Sledge GW, Miller KD. Exploiting the hallmarks of cancer: the future conquest of breast cancer. Eur J Cancer 2003, 39(12):1668-1675. http://dx.doi.org/10.1016/S0959-8049(03)00273-9, 10.1016/S0959-8049(03)00273-9, 12888360.
8. Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment?. Mol Cancer Ther 2003, 2(6):573-580. http://mct.aacrjournals.org/content/2/6/573.abstract.
9. Wong RSY. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 2011, 30:87. http://www.jeccr.com/content/30/1/87, 10.1186/1756-9966-30-87, 3197541, 21943236.
10. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998, 60:619-642. http://dx.doi.org/10.1146/annurev.physiol.60.1.619, 10.1146/annurev.physiol.60.1.619, 9558479.
11. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000, 21(3):485-495. http://dx.doi.org/10.1093/carcin/21.3.485, 10.1093/carcin/21.3.485, 10688869.
12. Simic MG, Bergtold DS, Karam LR. Generation of oxy radicals in biosystems. Mutation Res/Fundamental and Mol Mech of Mutagenesis 1989, 214(1):3-12. http://dx.doi.org/10.1016/0027-5107(89)90192-9.
13. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress and DNA damage in human carcinogenesis. Mutation Res/Fundamental and Mol Mech of Mutagenesis 2011, 711(1-2):193-201. http://dx.doi.org/10.1016/j.mrfmmm.2010.12.016.
14. Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, Lleonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev 2013, 12(1):376-390. http://dx.doi.org/10.1016/j.arr.2012.10.004, 10.1016/j.arr.2012.10.004, 23123177.
15. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996, 32(1):30-38. http://dx.doi.org/10.1016/0959-8049(95)00531-5.
16. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160(1):1-40. http://dx.doi.org/10.1016/j.cbi.2005.12.009, 10.1016/j.cbi.2005.12.009, 16430879.
17. Wen J, You K-R, Lee S-Y, Song C-H, Kim D-G. Oxidative stress-mediated apoptosis: the anticancer effect of the sesquiterpene lactone parthenolide. J Biol Chem 2002, 277(41):38954-38964. http://dx.doi.org/10.1074/jbc.M203842200, 10.1074/jbc.M203842200, 12151389.
18. Afzal S, Jensen S, Sørensen J, Henriksen T, Weimann A, Poulsen H. Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin. Cancer Chemother Pharmacol 2012, 69(2):301-307. http://dx.doi.org/10.1007/s00280-011-1700-2, 10.1007/s00280-011-1700-2, 21710244.
19. Alexandre J, Hu Y, Lu W, Pelicano H, Huang P. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 2007, 67(8):3512-3517. http://dx.doi.org/10.1158/0008-5472.can-06-3914, 10.1158/0008-5472.CAN-06-3914, 17440056.
20. Nazarewicz RR, Zenebe WJ, Parihar A, Larson SK, Alidema E, Choi J, Ghafourifar P. Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase. Cancer Res 2007, 67(3):1282-1290. http://dx.doi.org/10.1158/0008-5472.can-06-3099, 10.1158/0008-5472.CAN-06-3099, 17283165.
21. Graham JG, Quinn ML, Fabricant DS, Farnsworth NR. Plants used against cancer - an extension of the work of Jonathan Hartwell. J Ethnopharmacol 2000, 73:347-377. http://www.sciencedirect.com/science/article/pii/S037887410000341X, 10.1016/S0378-8741(00)00341-X, 11090989.
22. Farnsworth NR. The Role of Etnopharmacology in Drug Development 1990, England: John Wiley Chichester, http://www.ncbi.nlm.nih.gov/pubmed/2086037.
23. Liu JH. Activation of apoptosis pathways by different classes of anticancer drugs 2001, Hubei: University of Ulm, http://vts.uni-ulm.de/docs/2001/798/vts_798.pdf.
24. Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997, 89(6):1845-1853. http://bloodjournal.hematologylibrary.org/content/89/6/1845.short.
25. Debatin K-M. Activation of apoptosis pathways by anticancer treatment. Toxicol Lett 2000, 112-113(0):41-48. http://dx.doi.org/10.1016/S0378-4274(99)00252-0.
26. Hickman J. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992, 11(2):121-139. http://dx.doi.org/10.1007/BF00048059, 10.1007/BF00048059, 1327566.
27. Yeh CC, Tseng CN, Yang JI, Huang HW, Fang Y, Tang JY, Chang FR, Chang HW. Antiproliferation and induction of apoptosis in Ca9-22 oral cancer cells by ethanolic extract of gracilaria tenuistipitata. Molecules 2012, 17(9):10916-10927. http://www.mdpi.com/1420-3049/17/9/10916.
28. Yoo C-B, Han K-T, Cho K-S, Ha J, Park H-J, Nam J-H, Kil U-H, Lee K-T. Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett 2005, 225(1):41-52. http://dx.doi.org/10.1016/j.canlet.2004.11.018, 10.1016/j.canlet.2004.11.018, 15922856.
29. Altinok B, Sunguroglu A, Karadag A, Gurleyik E, Ozkan T, Aydos OS, Avci A. Antiproliferative, apoptotic and antioxidant activities of wheatgrass (Triticum aestivum L.) extract on CML (K562) cell line. Turkish J of Med Sci 2011, 41(4):657-663. http://journals.tubitak.gov.tr/medical/issues/sag-11-41-4/sag-41-4-13-0912-425.pdf.
30. Xiao D, Zeng Y, Prakash L, Badmaev V, Majeed M, Singh SV. Reactive oxygen species-dependent apoptosis by gugulipid extract of ayurvedic medicine plant commiphora mukul in human prostate cancer cells is regulated by c-Jun N-terminal kinase. The Am Soc for Pharmacol and Exp Ther 2010, 79:499-507. http://dx.doi.org/10.1124/mol.110.068551.
31. Chong KY, Tan HTW, Corlett RT. A checklist of the total vascular plant flora of Singapore: native, naturalised and cultivated species. Raffles Museum of Biodiversity Research, National University of Singapore 2009, 273. Singapore: Raffles Museum of Biodiversity Research, National University of Singapore, http://rmbr.nus.edu.sg/raffles_museum_pub/flora_of_singapore_tc.pdf.
32. U.S. Department Agriculture ARS National Genetic Resources Program 2011, USA: Germplasm Resources Information Network (GRIN). Online searchable database, http://www.ars-grin.gov/cgi-bin/npgs/html/index.pl, U.S. Department Agriculture ARS.
33. Ahmad FB, Holdsworth DK. Traditional medicinal plants of Sabah, Malaysia part III. The Rungus people of Kudat. Int J Pharmacogn 1995, 33:262-264. http://dx.doi.org/10.3109/13880209509065377.
34. Hanum F, Hamzah N. The use of medicinal plant species by the Temuan tribe of Ayer Hitam Forest, Selangor, Peninsular Malaysia. Pertanika J of Tropical Agri 1999, 22(2):85-94. http://psasir.upm.edu.my/3802/1/The_Use_of_Medicinal_Plant_Species_by_the_Temuan_Tribe_of_Ayer_Hitam.pdf.
35. Wiart C, Mogana S, Khalifah S, Mahan M, Ismail S, Buckle M, Narayana AK, Sulaiman M. Antimicrobial screening of plants used for traditional medicine in the state of Perak, Peninsular Malaysia. Fitoterapia 2004, 75(1):68-73. http://www.sciencedirect.com/science/article/pii/S0367326X03002089, 10.1016/j.fitote.2003.07.013, 14693223.
36. Muliawan SY. Effect of Dillenia suffruticosa extract on dengue virus type 2 replication. Universa Med 2008, 27(1):1-5. http://www.univmed.org/wp-content/uploads/2011/02/dr.sylvia.pdf.
37. Armania N, Yazan L, Musa SN, Ismail IS, Foo JB, Chan KW, Noreen H, Hisyam AH, Zulfahmi S, Ismail M. Dillenia suffruticosa exhibited antioxidant and cytotoxic activity through induction of apoptosis and G2/M cell cycle arrest. J Ethnopharmacol 2013, 146(2):525-535. http://dx.doi.org/10.1016/j.jep.2013.01.017, 10.1016/j.jep.2013.01.017, 23353897.
38. Wang CZ, Li XL, Wang QF, Mehendale SR, Yuan CS. Selective fraction of Scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells. Phytomedicine 2010, 17(1):63-68. http://dx.doi.org/10.1016/j.phymed.2009.07.003, 10.1016/j.phymed.2009.07.003, 2789205, 19836937.
39. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65(1-2):55-63. http://dx.doi.org/10.1016/0022-1759(83)90303-4.
40. Hanahan D, Weinberg Robert A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013, 10.1016/j.cell.2011.02.013, 21376230.
41. Fulda S. Modulation of apoptosis by natural products for cancer therapy. Planta Med 2010, 76(EFirst):1075-1079. http://dx.doi.org/10.1055/s-0030-1249961.
42. Bailly C. Ready for a comeback of natural products in oncology. Biochem Pharmacol 2009, 77(9):1447-1457. http://dx.doi.org/10.1016/j.bcp.2008.12.013, 10.1016/j.bcp.2008.12.013, 19161987.
43. Taraphdar AK, Roy M, Bhattacharya RK. Natural products as inducers of apoptosis: implication for cancer therapy and prevention. Curr Sci 2001, 80(11):1387-1396. http://www.iisc.ernet.in/currsci/jun102001/1387.pdf.
44. Man S, Gao W, Zhang Y, Huang L, Liu C. Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia 2010, 81(7):703-714. http://dx.doi.org/10.1016/j.fitote.2010.06.004, 10.1016/j.fitote.2010.06.004, 20550961.
45. Zhiyu W, Yue C, Neng W, Mei WD, Wei LY, Feng H, Gang SJ, De Po Y, Yuan GX, Jian-Ping C. Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biol & Therapy 2012, 13(3):138-147. http://www.landesbioscience.com/journals/cbt/article/18693/.
46. Yeh CT, Rao YK, Yao CJ, Yeh CF, Li CH, Chuang SE, Luong JHT, Lai GM, Tzeng YM. Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett 2009, 285(1):73-79. http://dx.doi.org/10.1016/j.canlet.2009.05.002, 10.1016/j.canlet.2009.05.002, 19477064.
47. Lamoral-Theys D, Pottier L, Dufrasne F, Neve J, Dubois J, Kornienko A, Kiss R, Ingrassia L, Lamoral-Theys D, Pottier L, Dufrasne F, Neve J, Dubois J, Kornienko A, Kiss R, Ingrassia L. Natural polyphenols that display anticancer properties through inhibition of kinase activity. Curr Med Chem 2010, 17(814):812-825. http://dx.doi.org/10.2174/092986710790712183.
48. Kuttan G, Kumar KB, Guruvayoorappan C, Kuttan R. Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv Exp Med Biol 2007, 595:173-184. http://link.springer.com/chapter/10.1007%2F978-0-387-46401-5_6, 10.1007/978-0-387-46401-5_6, 17569210.
49. Barton-Burke M, Wilkes GM. Cancer Therapies 2006, United States of America: Jones and Barlett's books, 10.
50. Ozawa S, Sugiyama Y, Mitsuhashi Y, Kobayashi T, Inaba M. Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration-time product. Cancer Chemother Pharmacol 1988, 21(3):185-190. http://dx.doi.org/10.1007/bf00262767.
51. Fadok VA, Voelker DR, Campbell PA, Cohen JJ DLB, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992, 148:2207. http://www.jimmunol.org/content/148/7/2207.long.
52. Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995, 184(1):39-51. http://dx.doi.org/10.1016/0022-1759(95)00072-I, 10.1016/0022-1759(95)00072-I, 7622868.
53. Zhang G, Gurtu V, Kain SR, Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. BioTechniques 1997, 23:525-531. http://www.biotechniques.com/multimedia/archive/00011/97233pf01_11715a.pdf.
54. Schutte B, Nuydens R, Geerts H, Ramaekers F. Annexin V binding assay as a tool to measure apoptosis in differentiated neuronal cells. J Neurosci Methods 1998, 86(1):63-69. http://dx.doi.org/10.1016/S0165-0270(98)00147-2, 10.1016/S0165-0270(98)00147-2, 9894786.
55. Jänicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998, 273(16):9357-9360. http://dx.doi.org/10.1074/jbc.273.16.9357, 10.1074/jbc.273.16.9357, 9545256.
56. Jänicke R. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 2009, 117(1):219-221. http://dx.doi.org/10.1007/s10549-008-0217-9, 10.1007/s10549-008-0217-9, 18853248.
57. Mooney LM, Al-Sakkaf KA, Brown BL, Dobson PR. Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells. Br J Cancer 2002, 87(8):909-917. http://europepmc.org/abstract/MED/12373608, 10.1038/sj.bjc.6600541, 2376174, 12373608.
58. Kasibhatla S, Genestier L, Green DR. Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB. J Biol Chem 1999, 274(2):987-992. http://dx.doi.org/10.1074/jbc.274.2.987, 10.1074/jbc.274.2.987, 9873041.
59. Kong Q, Beel JA, Lillehei KO. A threshold concept for cancer therapy. Med Hypotheses 2000, 55(1):29-35. http://dx.doi.org/10.1054/mehy.1999.0982, 10.1054/mehy.1999.0982, 11021322.
60. Kinnula VL, Crapo JD. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 2004, 36(6):718-744. http://dx.doi.org/10.1016/j.freeradbiomed.2003.12.010, 10.1016/j.freeradbiomed.2003.12.010, 14990352.
61. Salganik RI. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001, 20(5):464S-472S. http://www.ncbi.nlm.nih.gov/pubmed/11603657.
62. Miller WH, Ratna S, Rincón SVD, Rousseau. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway. Oncogene 2002, 22(3353):3360. http://dx.doi.org/10.1038/sj.onc.1206485.
63. Diao Y, Huang YQ, Zhang GD, Huang KF. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Int Immunopharmacol 2012, 12(2):334-341. http://dx.doi.org/10.1016/j.intimp.2011.12.004, 10.1016/j.intimp.2011.12.004, 22182776.
64. Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci 2001, 98(20):10983-10985. http://dx.doi.org/10.1073/pnas.211430998, 10.1073/pnas.211430998, 58668, 11572954.
65. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J of Cell Physiol 2002, 192(1):15. http://dx.doi.org/10.1002/jcp.10119.
66. Chang YJ, Huang YP, Li ZL, Chen CH. GRP78 Knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells. PLoS ONE 2012, 7(4):e35123. http://dx.doi.org/10.1371/journal.pone.0035123s, 10.1371/journal.pone.0035123, 3329422, 22529978.
67. Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res 2006, 66(8):3963-3966. http://dx.doi.org/10.1158/0008-5472.can-06-0743, 10.1158/0008-5472.CAN-06-0743, 16618711.
68. Bates S, Vousden KH. Mechanisms of p53-mediated apoptosis. Cell Mol Life Sci 1999, 55:28-37. http://www.ncbi.nlm.nih.gov/pubmed/10065149sss, 10.1007/s000180050267, 10065149.
69. Robbins D, Zhao Y. Oxidative stress induced byMnSOD-p53 interaction: Pro- or anti-tumorigenic?. J of Signal Transduct 2012, 2012:1-13. http://dx.doi.org/10.1155/2012/101465.
70. Sethi G, Sung B, Aggarwal BB. Nuclear factor-κB activation: from bench to bedside. Exp Biol and Med 2008, 233(1):21-31. http://dx.doi.org/10.3181/0707-mr-196.
71. Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, Yamazaki K, Nakabayashi M, Ogihara T, Kaneda Y. Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001, 38(1):48-55. http://dx.doi.org/10.1161/01.hyp.38.1.48, 10.1161/01.HYP.38.1.48, 11463759.
72. Martin AG. NFkB anti-apoptotic or pro-apoptotic, maybe both. Cell Cycle 2010, 9(16):3131-3132. http://www.mendeley.com/download/public/14520753/4840739732/054ce21125d09cd5018cfb8b4e375f6646499037/dl.pdf, 10.4161/cc.9.16.12780, 20724840.
73. Janssen-Heininger YMW, Poynter ME, Baeuerle PA. Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb. Free Radic Biol Med 2000, 28(9):1317-1327. http://dx.doi.org/10.1016/S0891-5849(00)00218-5, 10.1016/S0891-5849(00)00218-5, 10924851.
74. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005, 15:11-18. http://dx.doi.org/doi:10.1038/sj.cr.7290257, 10.1038/sj.cr.7290257, 15686620.
75. Park K-R, Nam D, Yun H-M, Lee S-G, Jang H-J, Sethi G, Cho SK, Ahn KS. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett 2011, 312(2):178-188. http://dx.doi.org/10.1016/j.canlet.2011.08.001, 10.1016/j.canlet.2011.08.001, 21924548.
76. Massaoka MH, Matsuo AL, Figueiredo CR, Farias CF, Girola N, et al. Jacaranone induces apoptosis in melanoma cells via ROS-mediated downregulation of Akt and p38 MAPK activation and displays antitumor activity in vivo. PLoS ONE 2012, 7(6):e38698. http://dx.doi.org/10.1371/journal.pone.0038698, 10.1371/journal.pone.0038698, 3368838, 22701695.
77. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 2001, 276(32):30359-30365. http://dx.doi.org/10.1074/jbc.M009698200, 10.1074/jbc.M009698200, 11387313.
78. Romashkova JA, Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401(86):90. http://dx.doi.org/10.1038/43474.
79. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996, 274(5288):787-789. http://dx.doi.org/10.1126/science.274.5288.787, 10.1126/science.274.5288.787, 8864120.